Red cell distribution width as a new prognostic biomarker in refractory chronic graft-<i>versus</i>-host disease

• Eduard Schulz,
• Filip Pirsl,
• Noa G. Holtzman,
• David Beshensky,
• Edward W. Cowen,
• Sandra A. Mitchell,
• Seth M. Steinberg,
• Steven Z. Pavletic

Affiliations

Eduard Schulz

Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892; Myeloid Malignancies Program, National Institutes of Health, Bethesda, MD 20892

Filip Pirsl

Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892

Noa G. Holtzman

Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892; Myeloid Malignancies Program, National Institutes of Health, Bethesda, MD 20892

David Beshensky

Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892

Edward W. Cowen

Dermatology Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD 20892

Sandra A. Mitchell

Outcomes Research Branch, Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD, 20850

Seth M. Steinberg

Biostatistics and Data Management Section, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892

Steven Z. Pavletic

Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892; Myeloid Malignancies Program, National Institutes of Health, Bethesda, MD 20892